Pricing
Login
Home
Charts
Search
Watchlist
Products

RPG Life Sciences Ltd

RPGLIFE
₹2,540.90-2.50%20 Nov 2026
Reports
Pharma Formulations

RPG Life Sciences Ltd

RPGLIFE
₹2,540.90
-2.50%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹4,202Cr
Close
Close Price
₹2,540.90
Industry
Industry
Pharma Formulations
PE
Price To Earnings
37.91
PS
Price To Sales
5.50
Revenue
Revenue
₹764Cr
Rev Gr TTM
Revenue Growth TTM
14.68%
PAT Gr TTM
PAT Growth TTM
-48.55%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
173143169182180177196212
Growth YoY
Revenue Growth YoY%
4.223.615.816.5
Expenses
ExpensesCr
124118133143140144152171
Operating Profit
Operating ProfitCr
4925353940334440
OPM
OPM%
28.517.821.021.522.118.622.319.1
Other Income
Other IncomeCr
3115516-51444
Interest Expense
Interest ExpenseCr
00000011
Depreciation
DepreciationCr
55555667
PBT
PBTCr
47135354929404137
Tax
TaxCr
1218913710119
PAT
PATCr
35117263722303128
Growth YoY
PAT Growth YoY%
-36.6-74.516.3-23.4
NPM
NPM%
20.282.015.620.312.316.915.613.3
EPS
EPS₹
21.171.015.922.313.418.118.517.1
QuarterDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
173143169182180177196212
Growth YoY
Revenue Growth YoY%
4.223.615.816.5
Expenses
ExpensesCr
124118133143140144152171
Operating Profit
Operating ProfitCr
4925353940334440
OPM
OPM%
28.517.821.021.522.118.622.319.1
Other Income
Other IncomeCr
3115516-51444
Interest Expense
Interest ExpenseCr
00000011
Depreciation
DepreciationCr
55555667
PBT
PBTCr
47135354929404137
Tax
TaxCr
1218913710119
PAT
PATCr
35117263722303128
Growth YoY
PAT Growth YoY%
-36.6-74.516.3-23.4
NPM
NPM%
20.282.015.620.312.316.915.613.3
EPS
EPS₹
21.171.015.922.313.418.118.517.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026TTM
Revenue
RevenueCr
653708764
Growth
Revenue Growth%
8.314.7
Expenses
ExpensesCr
494560608
Operating Profit
Operating ProfitCr
160147157
OPM
OPM%
24.420.820.5
Other Income
Other IncomeCr
952917
Interest Expense
Interest ExpenseCr
112
Depreciation
DepreciationCr
212124
PBT
PBTCr
233154148
Tax
TaxCr
503937
PAT
PATCr
183115111
Growth
PAT Growth%
-37.1-48.5
NPM
NPM%
28.016.314.5
EPS
EPS₹
110.869.667.0
Financial YearMar 2025Mar 2026TTM
Revenue
RevenueCr
653708764
Growth
Revenue Growth%
8.314.7
Expenses
ExpensesCr
494560608
Operating Profit
Operating ProfitCr
160147157
OPM
OPM%
24.420.820.5
Other Income
Other IncomeCr
952917
Interest Expense
Interest ExpenseCr
112
Depreciation
DepreciationCr
212124
PBT
PBTCr
233154148
Tax
TaxCr
503937
PAT
PATCr
183115111
Growth
PAT Growth%
-37.1-48.5
NPM
NPM%
28.016.314.5
EPS
EPS₹
110.869.667.0
Sales CAGR
1 Year8%
3 Years-
5 Years-
TTM15%
EBITDA CAGR
1 Year-8%
3 Years-
5 Years-
TTM5%
PAT CAGR
1 Year-37%
3 Years-
5 Years-
TTM-49%
Avg. ROCE
1 Year25%
3 Years-
5 Years-
TTM21%
CFO / EBITDA
1 Year38%
3 Years-
5 Years-
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
131313
Reserves
ReservesCr
517592674
Current Liabilities
Current LiabilitiesCr
120161229
Non Current Liabilities
Non Current LiabilitiesCr
72721
Total Liabilities
Total LiabilitiesCr
6587931,116
Current Assets
Current AssetsCr
465559670
Non Current Assets
Non Current AssetsCr
193234446
Total Assets
Total AssetsCr
6587931,116
Financial YearMar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
131313
Reserves
ReservesCr
517592674
Current Liabilities
Current LiabilitiesCr
120161229
Non Current Liabilities
Non Current LiabilitiesCr
72721
Total Liabilities
Total LiabilitiesCr
6587931,116
Current Assets
Current AssetsCr
465559670
Non Current Assets
Non Current AssetsCr
193234446
Total Assets
Total AssetsCr
6587931,116

Cash Flow

Consolidated
Standalone
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
7857
Investing Cash Flow
Investing Cash FlowCr
-4286
Financing Cash Flow
Financing Cash FlowCr
-27-21
Net Cash Flow
Net Cash FlowCr
9122
Free Cash Flow
Free Cash FlowCr
151-9
CFO To PAT
CFO To PAT%
42.549.1
CFO To EBITDA
CFO To EBITDA%
48.838.4
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
7857
Investing Cash Flow
Investing Cash FlowCr
-4286
Financing Cash Flow
Financing Cash FlowCr
-27-21
Net Cash Flow
Net Cash FlowCr
9122
Free Cash Flow
Free Cash FlowCr
151-9
CFO To PAT
CFO To PAT%
42.549.1
CFO To EBITDA
CFO To EBITDA%
48.838.4

Ratios

Consolidated
Standalone
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3,7673,0604,202
Price To Earnings
Price To Earnings
20.626.637.9
Price To Sales
Price To Sales
5.84.35.5
Price To Book
Price To Book
7.15.06.1
EV To EBITDA
EV To EBITDA
22.719.626.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
60.057.457.4
OPM
OPM%
24.420.820.5
NPM
NPM%
28.016.314.5
ROCE
ROCE%
44.024.821.1
ROE
ROE%
34.519.016.1
ROA
ROA%
27.914.59.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3,7673,0604,202
Price To Earnings
Price To Earnings
20.626.637.9
Price To Sales
Price To Sales
5.84.35.5
Price To Book
Price To Book
7.15.06.1
EV To EBITDA
EV To EBITDA
22.719.626.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
60.057.457.4
OPM
OPM%
24.420.820.5
NPM
NPM%
28.016.314.5
ROCE
ROCE%
44.024.821.1
ROE
ROE%
34.519.016.1
ROA
ROA%
27.914.59.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr6,1475,0244,2844,2024,1942,9012,757
Close PriceClose₹377.551,090.804,128.402,540.90418.251,693.90317.05
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE19.6235.5244.6737.9152.4151.4932.48
Price To SalesPS2.696.996.865.504.063.343.66
RevenueRevenueCr2,2897196247641,032870753
Revenue Growth TTMRev Gr TTM%10.2%39.0%47.7%14.7%18.2%30.1%
PAT Growth TTMPAT Gr TTM%39.0%60.2%95.7%-48.5%40.7%-64.3%
Market CapitalizationMkt CapCr6,1475,0244,2844,2024,1942,9012,757
Close PriceClose₹377.551,090.804,128.402,540.90418.251,693.90317.05
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE19.6235.5244.6737.9152.4151.4932.48
Price To SalesPS2.696.996.865.504.063.343.66
RevenueRevenueCr2,2897196247641,032870753
Revenue Growth TTMRev Gr TTM%10.2%39.0%47.7%14.7%18.2%30.1%
PAT Growth TTMPAT Gr TTM%39.0%60.2%95.7%-48.5%40.7%-64.3%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Mar 26
ResultPPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
ResultPPT
Transcript
Summary
Dec 24
ResultPPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
ResultPPT
Transcript
Summary
Mar 24
ResultPPT
Transcript
Summary
Dec 23
ResultPPT
Transcript
Summary
Sep 23
ResultPPT
Transcript
Summary
Jun 23
ResultPPT
Transcript
Summary
Mar 23
ResultPPT
Transcript
Summary
Dec 22
ResultPPT
Transcript
Summary
Sep 22
ResultPPT
Transcript
Summary
Jun 22
ResultPPT
Transcript
Summary
Mar 22
ResultPPT
Transcript
Summary
Dec 21
ResultPPT
Transcript
Summary
Sep 21
ResultPPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
ResultPPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Mar 26
ResultPPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
ResultPPT
Transcript
Summary
Dec 24
ResultPPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
ResultPPT
Transcript
Summary
Mar 24
ResultPPT
Transcript
Summary
Dec 23
ResultPPT
Transcript
Summary
Sep 23
ResultPPT
Transcript
Summary
Jun 23
ResultPPT
Transcript
Summary
Mar 23
ResultPPT
Transcript
Summary
Dec 22
ResultPPT
Transcript
Summary
Sep 22
ResultPPT
Transcript
Summary
Jun 22
ResultPPT
Transcript
Summary
Mar 22
ResultPPT
Transcript
Summary
Dec 21
ResultPPT
Transcript
Summary
Sep 21
ResultPPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
ResultPPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews